Is EAAT2 a potential therapeutic intervention target for Alzheimer's disease?

被引：0
|
作者：
Oliver WG Wood [1 ]
Jason HY Yeung [1 ]
Andrea Kwakowsky [1 ,2 ]
机构：
[1] Centre for Brain Research,Department of Anato my and Medical Imaging,Faculty of Medical and Health Sciences,University of Auckland
[2] Pharmacology and Therapeutics,School of Medicine,Galway N euroscience Centre,Ollscoil na Gaillimhe-U niversity of Galway
来源：
Neural Regeneration Research | 2023年 / 18卷 / 08期
关键词：
Alzheimer; Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease;
D O I：
暂无
中图分类号：
R749.16 [];
学科分类号：
100203 ;
摘要：
Alzheimer’s disease (AD) is the most common form of dementia worldwide,impairing memory and cognitive functions due to widespread neuronal death.The global incidence of this neurodegenerative disorder is predicted to increase rapidly in the near future.This growth in prevalence of AD will create a large burden for health systems worldwide.Further research into new therapeutic avenues is therefore crucial,
引用
收藏
页码：1721 / 1722
页数：2
相关论文
共 50 条
  • [1] Is EAAT2 a potential therapeutic intervention target for Alzheimer's disease?
    Wood, Oliver W. G.
    Yeung, Jason H. Y.
    Kwakowsky, Andrea
    NEURAL REGENERATION RESEARCH, 2023, 18 (08) : 1721 - 1722
  • [2] EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review
    Wood, Oliver W. G.
    Yeung, Jason H. Y.
    Faull, Richard L. M.
    Kwakowsky, Andrea
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [3] Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease
    Takahashi, Kou
    Kong, Qiongman
    Lin, Yuchen
    Stouffer, Nathan
    Schulte, Delanie A.
    Lai, Liching
    Liu, Qibing
    Chang, Ling-Chu
    Dominguez, Sky
    Xing, Xuechao
    Cuny, Gregory D.
    Hodgetts, Kevin J.
    Glicksman, Marcie A.
    Lin, Chien-Liang Glenn
    JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (03): : 319 - 332
  • [4] Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease
    Takahashi, Kou
    Foster, Joshua B.
    Lin, Chien-Liang Glenn
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (18) : 3489 - 3506
  • [5] Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease
    Kou Takahashi
    Joshua B. Foster
    Chien-Liang Glenn Lin
    Cellular and Molecular Life Sciences, 2015, 72 : 3489 - 3506
  • [6] EAAT2 splice variants in Alzheimer disease
    Dodd, PR
    Innes, DJ
    Gebhardt, FM
    Walton, HA
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 87 - 87
  • [7] Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease
    Limpert, Allison S.
    Cosford, Nicholas D. P.
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (03): : 964 - 967
  • [8] Microglia in Alzheimer's Disease: A Target for Therapeutic Intervention
    Zhang, Guimei
    Wang, Zicheng
    Hu, Huiling
    Zhao, Meng
    Sun, Li
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [9] Serum expression of EAAT2 and ADORA2A in patients with different degrees of Alzheimer's disease
    Meng, S-X
    Wang, B.
    Li, W-T
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (22) : 11783 - 11792
  • [10] Clusterin is a Potential Therapeutic Target in Alzheimer's Disease
    Palihati, Nazhakaiti
    Tang, Yuanhong
    Yin, Yajuan
    Yu, Ding
    Liu, Gang
    Quan, Zhenzhen
    Ni, Junjun
    Yan, Yan
    Qing, Hong
    MOLECULAR NEUROBIOLOGY, 2023, 61 (7) : 3836 - 3850
12345